Real-time enrollment status for this rhabdomyosarcoma clinical trial
Current Status
Recruiting
Checked: September 14, 2026 at 7:08 PM UTC
| NCT Number | NCT07466316 |
| Recruiting Status | Recruiting |
| Condition | Rhabdomyosarcoma |
| Phase | PHASE3 |
| Target Enrollment | 342 participants |
| Active Locations | 86 sites in the US |
| Sponsor | Children's Oncology Group |
| Last Updated on CT.gov | August 25, 2026 (2 weeks ago) |
As of September 14, 2026: Clinical trial NCT07466316 is currently recruiting participants. This phase3 study for rhabdomyosarcoma is actively seeking new participants at 86 locations across the United States. The study is sponsored by Children's Oncology Group. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07466316 is actively recruiting participants as of September 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 86 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07466316 was last updated 2 weeks ago (August 25, 2026). HelloStudys verifies this status automatically.